MedMen Enriches Its Marijuana Brand Portfolio With Boutique Strains From Fog City Farms

Cannabis retailer MedMen Enterprises Inc. MMEN MMNFF is expanding its brand portfolio with new products from Fog City Farms, a Santa Cruz-based cannabis cultivation company. Fog City Farms is known for specializing in sustainable growing and business practices, with an emphasis on boutique strains.

Starting January 23, unique small-batch strains cultivated in Fog City’s state-of-the-art vertical growing platform will be available at select MedMen locations across California.

“MedMen is proud to stock the latest strains from Fog City Farms, a sustainably-minded cultivator with a deeply-rooted history in Northern California’s legendary cannabis scene,” stated Tyson Rossi, SVP of product and revenue at MedMen. “Cultivated with forward-thinking farming practices and a focus on boutique cultivars, Fog City Farms’ cannabis products mark another strategic addition to our diverse brand roster, which we continue to expand in pursuit of best-in-class products for our growing customer base.”

MedMen will stock a wide range of Fog City Farms products, including the brand’s inaugural limited-edition collaboration with Hashbone – a line of premium, solventless hash-infused pre-rolls featuring artisan blends of top-shelf flower and cold-water bubble hash.

The Los Angeles-headquartered company noted that this latest portfolio expansion is a testament to MedMen’s new era of post-turnaround accelerated growth and demonstrates the company’s commitment to trusted, high-quality products and unparalleled service.

More recent news from MedMen:

MedMen Still Refusing To Close $73M Transaction With Ascend Wellness Regarding New York Properties

Ascend Wellness Gets Green Light From New York State To Invest $73M In MedMen's Subsidiary

MedMen Opens New Store In Boston's Fenway Park On Heels Of Litigation Hurdles & Management Shakeups

MedMen To Carry Iconic LA Cannabis Brand Jungle Boys

Price Action

MedMen shares closed Monday market session 0.59% lower at 17 cents per share.

Photo: Courtesy of Wesley Gibbs on Unsplash